174 related articles for article (PubMed ID: 9915099)
1. American Pharmaceutical Association review of literature on prescription to over-the-counter drug switches.
Schulke DG
Clin Ther; 1998; 20 Suppl C():C124-33. PubMed ID: 9915099
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
Madhaven S
J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
[TBL] [Abstract][Full Text] [Related]
3. Impact of vaginal antifungal products on utilization of health care services: evidence from physician visits.
Lipsky MS; Waters T; Sharp LK
J Am Board Fam Pract; 2000; 13(3):178-82. PubMed ID: 10826865
[TBL] [Abstract][Full Text] [Related]
4. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
5. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
7. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
[TBL] [Abstract][Full Text] [Related]
8. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC).
Watson MC; Bond CM;
Pharm World Sci; 2003 Aug; 25(4):129-34. PubMed ID: 12964489
[TBL] [Abstract][Full Text] [Related]
10. Evolution of self-care with over-the-counter medications.
Soller RW
Clin Ther; 1998; 20 Suppl C():C134-40. PubMed ID: 9915100
[TBL] [Abstract][Full Text] [Related]
11. Women's use of over-the-counter antifungal medications for gynecologic symptoms.
Ferris DG; Dekle C; Litaker MS
J Fam Pract; 1996 Jun; 42(6):595-600. PubMed ID: 8656170
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting.
Watson MC; Bond CM; Grimshaw J; Johnston M
Qual Saf Health Care; 2006 Feb; 15(1):53-7. PubMed ID: 16456211
[TBL] [Abstract][Full Text] [Related]
13. Prescription to over-the-counter switches: the physician perspective.
Byrns PJ
Clin Ther; 1998; 20 Suppl C():C118-23. PubMed ID: 9915098
[TBL] [Abstract][Full Text] [Related]
14. New OTC drugs and devices 2002: a selective review.
Newton GD; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2003; 43(2):249-60. PubMed ID: 12688440
[TBL] [Abstract][Full Text] [Related]
15. Switching from prescription to over-the counter medications: a consumer and managed care perspective.
Pawaskar MD; Balkrishnan R
Manag Care Interface; 2007 Jan; 20(1):42-7. PubMed ID: 17310652
[TBL] [Abstract][Full Text] [Related]
16. New OTC drugs and devices 2001: a selective review.
Newton GD; Benninghoff AJ; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2002; 42(2):267-77. PubMed ID: 11926667
[TBL] [Abstract][Full Text] [Related]
17. Report of the 2013 APhA House of Delegates.
J Am Pharm Assoc (2003); 2013; 53(4):365-7. PubMed ID: 23892807
[No Abstract] [Full Text] [Related]
18. The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?
McKenney JM; Brown WV; Cohen JD; Cahill E
Am J Cardiol; 2004 Nov; 94(9A):16F-21F. PubMed ID: 15519287
[TBL] [Abstract][Full Text] [Related]
19. Implications of a switch from prescription to over-the-counter status for allergy drugs.
Brass EP
Curr Allergy Asthma Rep; 2004 May; 4(3):245-50. PubMed ID: 15056408
[TBL] [Abstract][Full Text] [Related]
20. The costs and benefits of switching a drug from prescription-only to over-the-counter status: a review of methodological issues and current evidence.
Andersson F; Hatziandreu E
Pharmacoeconomics; 1992 Nov; 2(5):388-96. PubMed ID: 10147051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
